SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-004132
Filing Date
2014-08-29
Accepted
2014-08-29 13:04:32
Documents
2
Period of Report
2014-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILING DOCUMENT document.htm 8-K 11632
2 PRESS RELEASE newsrelease.htm EX-99 5530
  Complete submission text file 0001171843-14-004132.txt   18308
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 141074454
SIC: 2836 Biological Products, (No Diagnostic Substances)